IGEA Pharma NV
F:3B5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IGEA Pharma NV
F:3B5
|
NL |
|
W
|
Woory Industrial Holdings Co Ltd
KOSDAQ:072470
|
KR |
Bankruptcy Probability
IGEA Pharma NV's probability of bankruptcy is 6.5%, signalling a meaningful chance of default. The solvency score is 29/100 — a sign of moderate financial strength.
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IGEA Pharma NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
IGEA Pharma NV
SIX:IGPH
|
505.5k CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
188.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
130.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
119.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
117.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
67.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
51.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
33.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IGEA Pharma NV's probability of bankruptcy is 6.5%, signalling a meaningful chance of default.
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IGEA Pharma NV has total debt of 510k EUR. This includes both short-term (0 EUR) and long-term (510k EUR) debt.
You can find a full breakdown on its Balance Sheet.
